Literature DB >> 18416467

Primary gastric mucosa associated lymphoid tissue lymphoma: clinical data predicted treatment outcome.

Milena Todorovic1, Bela Balint, Miodrag Jevtic, Nada Suvajdzic, Amela Ceric, Dragana Stamatovic, Olivera Markovic, Maja Perunicic, Slobodan Marjanovic, Miodrag Krstic.   

Abstract

AIM: To determine clinical characteristics and treatment outcome of gastric lymphoma after chemotherapy and immuno-chemotherapy.
METHODS: Thirty four patients with primary gastric mucosa associated lymphoid tissue (MALT) lymphoma (Ann Arbor stages I to IV) were enrolled. All had upper gastric endoscopy, abdominal ultrasonography, CT and H pylori status assessment (histology and serology). After anti-H pylori treatment and initial chemotherapy, patients were re-examined every 4 mo.
RESULTS: Histological regression of the lymphoma was complete in 22/34 (64.7%) and partial in 9 (26.5%) patients. Median follow up time for these 31 responders was 60 mo (range 48-120). No regression was noted in 3 patients. Among the 25 (73.5%) H pylori positive patients, the eradication rate was 100%.
CONCLUSION: Using univariate analysis, predictive factors for overall survival were international prognostic index (IPI) score, hemoglobin level, erythrocyte sedimentation rate (ESR), and platelet numbers (P < 0.005). In addition to this, Cox proportion hazard model differentiate IPI score, ESR, and platelets as predictors of survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18416467      PMCID: PMC2705095          DOI: 10.3748/wjg.14.2388

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.

Authors:  H Ye; A Dogan; L Karran; T G Willis; L Chen; I Wlodarska; M J Dyer; P G Isaacson; M Q Du
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.

Authors:  K Ohshima; H Muta; C Kawasaki; K Muta; V Deyev; M Kanda; Y Kumano; E R Podack; M Kikuchi
Journal:  Int J Oncol       Date:  2001-08       Impact factor: 5.650

3.  Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.

Authors:  S Nakamura; T Matsumoto; H Suekane; M Takeshita; K Hizawa; M Kawasaki; T Yao; M Tsuneyoshi; M Iida; M Fujishima
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection.

Authors:  A Morgner; N Lehn; L P Andersen; C Thiede; M Bennedsen; K Trebesius; B Neubauer; A Neubauer; M Stolte; E Bayerdörffer
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

5.  [MALT-lymphoma].

Authors:  D Flieger; W Fischbach
Journal:  Praxis (Bern 1994)       Date:  2006-08-02

6.  Novel translocation of the BCL10 gene in a case of mucosa associated lymphoid tissue lymphoma.

Authors:  R Achuthan; S M Bell; J P Leek; P Roberts; K Horgan; A F Markham; P J Selby; K A MacLennan
Journal:  Genes Chromosomes Cancer       Date:  2000-12       Impact factor: 5.006

7.  Detection of the t(11;18) API2/MALT1 translocation associated with gastric MALT lymphoma in routine formalin-fixed, paraffin-embedded small endoscopic biopsy specimens by robust real-time RT-PCR.

Authors:  Weisu Zhang; Jorge Garces; Henry Y Dong
Journal:  Am J Clin Pathol       Date:  2006-12       Impact factor: 2.493

8.  Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.

Authors:  A Ruskoné-Fourmestraux; A Lavergne; P H Aegerter; F Megraud; L Palazzo; A de Mascarel; T Molina; J L Rambaud
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

9.  Gastric MALT lymphoma: clinical characteristics and prevalence of H. pylori infection in a series of 37 cases.

Authors:  J P Gisbert; B Aguado; M Luna; S Nistal; L M Asenjo; T Reina; A Acevedo; R Arranz
Journal:  Rev Esp Enferm Dig       Date:  2006-09       Impact factor: 2.086

10.  MALT lymphoma associated genetic aberrations occur at different frequencies in primary and secondary intestinal MALT lymphomas.

Authors:  B Streubel; G Seitz; M Stolte; P Birner; A Chott; M Raderer
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059

View more
  5 in total

1.  Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis.

Authors:  Hidekazu Suzuki; Yoshimasa Saito; Toshifumi Hibi
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

2.  Primary gastric plasmacytoma associated with Helicobacter pylori infection: a report of two cases with different prognosis.

Authors:  Hong-sheng Lu; Yun-feng Xu; Mei-fu Gan
Journal:  Int J Hematol       Date:  2010-05-12       Impact factor: 2.490

Review 3.  Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas.

Authors:  Marta-Isabel Pereira; José Augusto Medeiros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

4.  Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.

Authors:  Yong-Jin Park; Seung Hyup Hyun; Seung Hwan Moon; Kyung-Han Lee; Byung Hoon Min; Jun Haeng Lee; Won Seog Kim; Seok Jin Kim; Joon Young Choi
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

5.  Clinical significance of preoperative inflammatory parameters in gastric cancer patients.

Authors:  Deuk Young Lee; Seong Woo Hong; Yeo Goo Chang; Woo Yong Lee; Byungmo Lee
Journal:  J Gastric Cancer       Date:  2013-06-25       Impact factor: 3.720

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.